Professor Adrian Boswood
MA VetMB MRCVS DVC DipECVIM-CA (Cardiology)
Vice Principal for Learning, Teaching and Assessment
Department: Office of the Principal
Campus: Hawkshead
Research Groups: Cardiovascular and Renal Biology, CPCS (Research Programme)
Clinical Groups: Small Animal Cardiology
Adrian is Professor of Veterinary Cardiology at the ·¬ÇÑapp (RVC). He is a European Specialist in companion animal cardiology.
Adrian graduated from Cambridge University Veterinary School in 1989. After graduation he spent a year in mixed practice. He has worked at the RVC since joining as an Intern in 1990. He obtained the RCVS Certificate in Small Animal Cardiology in 1993 and the RCVS Diploma in Veterinary Cardiology in 1996. He obtained the ECVIM Cardiology Diploma in 2001.
Adrian's main research interests lie in the diagnosis, progression and treatment of acquired canine cardivascular diseases.
Wilshaw, J; Stein, M: Lotter, N; Elliott, J; Boswood, A
Journal of Small Animal Practice, 2021
Wilshaw, J.; Rosenthal, S.L.; Wess, G.; Dickson, D.; Bevilacqua, L.; Dutton, E.; Deinert, M.; Abrantes, R.; Schneider, I.; Oyama, M.A.; Gordon, S.G.; Elliott, J.; Xia, D.; and Boswood, A.
Journal of Veterinary Internal Medicine 2021
Mattin, M J; Brodbelt, D C; Church, D B; Boswood, A.
.
Journal of Veterinary Internal Medicine, 2019
Boswood A, Häggström J, Gordon SG, Wess G, Stepien RL, Oyama MA, Keene BW, Bonagura J, MacDonald KA, Patteson M, Smith S, Fox PR, Sanderson K, Woolley R, Szatmári V, Menaut P, Church WM, O'Sullivan ML, Jaudon JP, Kresken JG, Rush J, Barrett KA, Rosenthal SL, Saunders AB, Ljungvall I, Deinert M, Bomassi E, Estrada AH, Fernandez Del Palacio MJ, Moise NS, Abbott JA, Fujii Y, Spier A, Luethy MW, Santilli RA, Uechi M, Tidholm A, Watson P.
J Vet Intern Med. 2016 Nov;30(6):1765-1779. doi: 10.1111/jvim.14586. 2016
His main area of interest is small animal cardiorespiratory medicine
-
Researching heart disease in dogs - HAMLET and EPIC
Whilst there are a number of disease processes that affect the canine heart, mitral valve disease (MVD) is by far the most common. The HAMLET study aims to catch signs of this disease early by evaluating whether levels of serum cardiac biomarkers, interpreted alongside a patient’s clinical information, can determine which dogs are likely to have cardiac enlargement and therefore would benefit from further investigation or treatment. The EPIC study sought to determine whether the administration of pimobendan to dogs with preclinical MVD would delay the onset of clinical signs.